Jo N Fleming

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. ncbi Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis
    Jo Nadine Fleming
    Department of Pathology, University of Washington, Seattle, Washington, USA
    PLoS ONE 4:e6203. 2009
  2. ncbi Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?
    Jo N Fleming
    Department of Pathology, University of Washington, Seattle, Washington, United States of America
    PLoS ONE 3:e1452. 2008
  3. ncbi Is scleroderma a vasculopathy?
    Jo Nadine Fleming
    University of Washington School of Medicine, 815 Mercer Street, 419, Brotman Building, Seattle, WA 98109, USA
    Curr Rheumatol Rep 11:103-10. 2009

Detail Information

Publications3

  1. ncbi Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis
    Jo Nadine Fleming
    Department of Pathology, University of Washington, Seattle, Washington, USA
    PLoS ONE 4:e6203. 2009
    ..We compared the dermal microvasculature in human c-GVHD to SSc to determine if c-GVHD is a suitable model for SSc...
  2. ncbi Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?
    Jo N Fleming
    Department of Pathology, University of Washington, Seattle, Washington, United States of America
    PLoS ONE 3:e1452. 2008
    ..Scleroderma is an autoimmune disease with a characteristic vascular pathology. The vasculopathy associated with scleroderma is one of the major contributors to the clinical manifestations of the disease...
  3. ncbi Is scleroderma a vasculopathy?
    Jo Nadine Fleming
    University of Washington School of Medicine, 815 Mercer Street, 419, Brotman Building, Seattle, WA 98109, USA
    Curr Rheumatol Rep 11:103-10. 2009
    ..We offer a hypothesis that places vascular injury at the center of this disease and also suggest possible clinical approaches for arresting and/or reversing the disease...